By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sigma-Aldrich today reported a 2 percent increase in fourth quarter revenues to $582 million, a new quarterly high, but short of analysts' expectations.

The figure for the three months ended Dec. 31, 2010, compares to $573 million for the fourth quarter of 2009. Wall Street expected revenues for the quarter of $587.5 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times' George Johnson muses on cancer's roots in multicellularity.

The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.

Jun Wang, the chief executive of BGI, has stepped down.

In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.